https://thepharmadata.com/kezar-board-rejects-unsolicited-concentra-proposal-and-implements-short-term-stockholder-rights-plan/ 2024-10-18T11:50:59+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Kezar-Board-Rejects-Unsolicited-Concentra-Proposal-and-Implements-Short-Term-Stockholder-Rights-Plan.webp https://thepharmadata.com/heartbeam-appoints-robert-eno-as-ceo-ahead-of-u-s-commercialization/ 2024-10-18T11:55:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/HeartBeam-Appoints-Robert-Eno-as-CEO-Ahead-of-U.S.-Commercialization.webp https://thepharmadata.com/peripheral-vascular-devices-market-forecast-2024-2032-key-players-include-abbott-and-medtronic/ 2024-10-18T12:03:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Peripheral-Vascular-Devices-Market-Forecast-2024-2032-Key-Players-Include-Abbott-and-Medtronic.webp https://thepharmadata.com/kezar-life-sciences-shares-positive-portola-trial-safety-review-for-zetomipzomib/ 2024-10-18T12:13:59+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Kezar-Life-Sciences-Shares-Positive-PORTOLA-Trial-Safety-Review-for-Zetomipzomib.webp https://thepharmadata.com/benevolentai-appoints-kenneth-mulvany-as-executive-chairman/ 2024-10-18T12:20:30+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/BenevolentAI-Appoints-Kenneth-Mulvany-as-Executive-Chairman.webp https://thepharmadata.com/dna-script-names-marc-montserrat-ceo-to-propel-long-term-growth-for-enzymatic-dna-synthesis/ 2024-10-18T12:25:54+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/DNA-Script-Names-Marc-Montserrat-CEO-to-Propel-Long-Term-Growth-for-Enzymatic-DNA-Synthesis.webp https://thepharmadata.com/modmed-unveils-cutting-edge-solutions-for-ophthalmology-practices-at-aao-2024/ 2024-10-18T12:32:16+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/ModMed-Unveils-Cutting-Edge-Solutions-for-Ophthalmology-Practices-at-AAO-2024.webp https://thepharmadata.com/clarametyx-biosciences-reports-advancements-in-cmtx-101-antibody-therapy-for-cystic-fibrosis-infections/ 2024-10-18T12:38:46+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Clarametyx-Biosciences-Reports-Advancements-in-CMTX-101-Antibody-Therapy-for-Cystic-Fibrosis-Infections.webp https://thepharmadata.com/komodo-health-unveils-real-time-drug-prescription-insights/ 2024-10-18T14:42:58+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Komodo-Health-Unveils-Real-Time-Drug-Prescription-Insights.webp https://thepharmadata.com/caresource-and-nomi-health-partner-to-enhance-healthcare-access-and-outcomes/ 2024-10-18T14:52:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/CareSource-and-Nomi-Health-Partner-to-Enhance-Healthcare-Access-and-Outcomes.webp https://thepharmadata.com/dia-canada-annual-meeting-to-focus-on-precision-regulation-and-clinical-trial-advancements/ 2024-10-18T14:57:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/DIA-Canada-Annual-Meeting-to-Focus-on-Precision-Regulation-and-Clinical-Trial-Advancements.webp https://thepharmadata.com/clearb-therapeutics-partners-with-adjuvance-for-saponin-adjuvant-to-present-hepatitis-b-data-at-aasld-2024/ 2024-10-18T15:18:35+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/ClearB-Therapeutics-Partners-With-Adjuvance-for-Saponin-Adjuvant-to-Present-Hepatitis-B-Data-at-AASLD-2024.webp https://thepharmadata.com/eclinicalworks-ai-tool-helps-york-primary-care-save-over-an-hour-daily-on-fax-management/ 2024-10-18T15:23:58+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/eClinicalWorks-AI-Tool-Helps-York-Primary-Care-Save-Over-an-Hour-Daily-on-Fax-Management.webp https://thepharmadata.com/upfront-joins-athenahealth-marketplace-to-boost-revenue-for-healthcare-enterprises/ 2024-10-18T15:30:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Upfront-Joins-athenahealth-Marketplace-to-Boost-Revenue-for-Healthcare-Enterprises.webp https://thepharmadata.com/byheart-expands-retail-presence-by-200-with-launch-in-walmart-whole-foods-and-wegmans/ 2024-10-18T15:41:46+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/ByHeart-Expands-Retail-Presence-by-200-with-Launch-in-Walmart-Whole-Foods-and-Wegmans.webp https://thepharmadata.com/wolters-kluwer-ai-labs-celebrates-first-year-of-collaboration-on-responsible-ai-features-for-uptodate/ 2024-10-18T15:57:52+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Wolters-Kluwer-AI-Labs-Celebrates-First-Year-of-Collaboration-on-Responsible-AI-Features-for-UpToDate.webp https://thepharmadata.com/2024-personalized-nutrition-market-report-types-forms-applications-and-end-use-markets/ 2024-10-18T16:04:31+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/2024-Personalized-Nutrition-Market-Report-Types-Forms-Applications-and-End-Use-Markets.webp https://thepharmadata.com/alnylam-files-application-for-vutrisiran-to-treat-attr-amyloidosis/ 2024-10-18T16:11:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Alnylam-Files-Application-for-Vutrisiran-to-Treat-ATTR-Amyloidosis.webp https://thepharmadata.com/sullivancotter-rising-healthcare-executive-pay-reflects-competitive-talent-market/ 2024-10-18T16:20:34+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/SullivanCotter-Rising-Healthcare-Executive-Pay-Reflects-Competitive-Talent-Market.webp https://thepharmadata.com/xaira-therapeutics-names-dr-debbie-law-as-chief-scientific-officer-and-julia-tran-as-chief-people-officer/ 2024-10-18T16:31:41+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Xaira-Therapeutics-Names-Dr.-Debbie-Law-as-Chief-Scientific-Officer-and-Julia-Tran-as-Chief-People-Officer.webp https://thepharmadata.com/medidata-launches-rave-lite-to-accelerate-early-and-late-stage-clinical-trial-growth/ 2024-10-19T09:59:31+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Medidata-Launches-Rave-Lite-to-Accelerate-Early-and-Late-Stage-Clinical-Trial-Growth.webp https://thepharmadata.com/mercks-clesrovimab-significantly-reduces-rsv-incidence-and-hospitalizations-in-infants/ 2024-10-19T10:05:52+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Mercks-Clesrovimab-Significantly-Reduces-RSV-Incidence-and-Hospitalizations-in-Infants.webp https://thepharmadata.com/celltrion-highlights-two-year-analysis-supporting-dose-escalation-for-ct-p13-sc-in-ibd/ 2024-10-19T10:11:59+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Celltrion-Highlights-Two-Year-Analysis-Supporting-Dose-Escalation-for-CT-P13-SC-in-IBD.webp https://thepharmadata.com/nordic-group-bv-expands-u-s-launch-of-lacrifill-gel-for-dry-eye-treatment/ 2024-10-19T10:17:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Nordic-Group-BV-Expands-U.S.-Launch-of-LACRIFILL®-Gel-for-Dry-Eye-Treatment.webp https://thepharmadata.com/kalvista-pharmaceuticals-to-showcase-data-at-2024-acaai-annual-scientific-meeting/ 2024-10-19T10:21:39+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/KalVista-Pharmaceuticals-to-Showcase-Data-at-2024-ACAAI-Annual-Scientific-Meeting.webp https://thepharmadata.com/actineer-the-joint-venture-of-itm-and-cnl-launches-actinium-225-production/ 2024-10-19T10:25:34+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Actineer-the-Joint-Venture-of-ITM-and-CNL-Launches-Actinium-225-Production.webp https://thepharmadata.com/ferring-pharmaceuticals-showcases-commitment-to-fertility-care-at-2024-asrm-congress/ 2024-10-19T10:32:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Ferring-Pharmaceuticals-Showcases-Commitment-to-Fertility-Care-at-2024-ASRM-Congress.webp https://thepharmadata.com/32-of-life-science-marketing-teams-lack-kpi-awareness-for-customer-engagement-investments/ 2024-10-19T10:39:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/32-of-Life-Science-Marketing-Teams-Lack-KPI-Awareness-for-Customer-Engagement-Investments.webp https://thepharmadata.com/biological-lattice-industries-secures-1-8-million-pre-seed-funding-from-uni-fund-to-democratize-biofabrication/ 2024-10-19T10:44:18+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Biological-Lattice-Industries-Secures-1.8-Million-Pre-Seed-Funding-from-Uni.Fund-to-Democratize-Biofabrication.webp https://thepharmadata.com/copd-drug-market-analysis-forecasts-2024-2033-high-unmet-needs-late-stage-therapies/ 2024-10-19T10:49:06+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/COPD-Drug-Market-Analysis-Forecasts-2024-2033-High-Unmet-Needs-Late-Stage-Therapies.webp https://thepharmadata.com/bioaffinity-technologies-prices-2-66-million-direct-offering-and-private-placement/ 2024-10-19T10:53:40+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/bioAffinity-Technologies-Prices-2.66-Million-Direct-Offering-and-Private-Placement.webp https://thepharmadata.com/high-potency-apis-hpapis-market-research-report-2023-2030-cmo-expansion-driving-growth/ 2024-10-19T10:59:02+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/High-Potency-APIs-HPAPIs-Market-Research-Report-2023-2030-CMO-Expansion-Driving-Growth.webp https://thepharmadata.com/ge-healthcare-foundations-pledge-1m-to-enhance-health-outcomes-in-milwaukee/ 2024-10-19T11:03:35+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/GE-HealthCare-Foundations-Pledge-1M-to-Enhance-Health-Outcomes-in-Milwaukee.webp https://thepharmadata.com/scholar-rock-announces-new-employee-inducement-grants-under-nasdaq-rule-5635c4/ 2024-10-19T11:08:33+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Scholar-Rock-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Rule-5635c4.webp https://thepharmadata.com/audax-private-equity-acquires-avantors-clinical-services-rebrands-as-resonant-clinical-solutions/ 2024-10-21T10:15:49+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Audax-Private-Equity-Acquires-Avantors-Clinical-Services-Rebrands-as-Resonant-Clinical-Solutions.webp https://thepharmadata.com/vertex-to-present-phase-3-data-on-suzetrigine-as-a-pain-signal-inhibitor-at-asa-meeting/ 2024-10-21T10:21:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Vertex-to-Present-Phase-3-Data-on-Suzetrigine-as-a-Pain-Signal-Inhibitor-at-ASA-Meeting.webp https://thepharmadata.com/ferring-pharmaceuticals-showcases-commitment-to-fertility-care-at-2024-asrm-congress-2/ 2024-10-21T10:25:10+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Ferring-Pharmaceuticals-Showcases-Commitment-to-Fertility-Care-at-2024-ASRM-Congress-2.webp https://thepharmadata.com/32-of-life-science-teams-lack-kpi-use-for-investment-decisions-in-customer-engagement/ 2024-10-21T10:30:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/32-of-Life-Science-Teams-Lack-KPI-Use-for-Investment-Decisions-in-Customer-Engagement.webp https://thepharmadata.com/biological-lattice-industries-raises-1-8m-pre-seed-funding-to-democratize-biofabrication/ 2024-10-21T10:36:10+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Biological-Lattice-Industries-Raises-1.8M-Pre-Seed-Funding-to-Democratize-Biofabrication.webp https://thepharmadata.com/bioaffinity-technologies-prices-2-66-million-registered-direct-offering-and-concurrent-private-placement/ 2024-10-21T10:40:48+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/bioAffinity-Technologies-Prices-2.66-Million-Registered-Direct-Offering-and-Concurrent-Private-Placement.webp https://thepharmadata.com/nuclidium-begins-phase-1-imaging-of-%e2%81%b6%c2%b9cu-radiotracer-for-psma-positive-prostate-cancer/ 2024-10-22T09:44:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/NUCLIDIUM-Begins-Phase-1-Imaging-of-⁶¹Cu-Radiotracer-for-PSMA-positive-Prostate-Cancer.webp https://thepharmadata.com/bruker-unveils-100-high-accuracy-plasma-proteome-advancing-glycoproteomics-and-metaproteomics/ 2024-10-22T09:51:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Bruker-Unveils-100-High-Accuracy-Plasma-Proteome-Advancing-Glycoproteomics-and-Metaproteomics.webp https://thepharmadata.com/beigene-gains-chmp-backing-for-tevimbra-in-first-line-treatment-of-gastric-and-esophageal-cancers/ 2024-10-22T10:04:37+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/BeiGene-Gains-CHMP-Backing-for-TEVIMBRA®-in-First-Line-Treatment-of-Gastric-and-Esophageal-Cancers.webp https://thepharmadata.com/catalent-releases-open-letter-to-customers-about-novo-holdings-acquisition/ 2024-10-22T10:12:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Catalent-Releases-Open-Letter-to-Customers-About-Novo-Holdings-Acquisition.webp https://thepharmadata.com/blue-lake-biotechnology-and-cyanvac-announce-presentation-on-intranasal-vaccine-candidates-at-the-international-society-for-vaccines-annual-congress/ 2024-10-22T11:29:16+05:30 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/seaport-therapeutics-closes-225-million-oversubscribed-series-b-financing-round/ 2024-10-22T11:32:58+05:30 https://thepharmadata.com/wp-content/uploads/2024/03/Summit-Therapeutics-to-Present-at-the-Barclays.webp https://thepharmadata.com/nuclidium-announces-first-patient-imaging-in-phase-1-trial-of-61cu-based-radiotracer-for-psma-positive-prostate-cancer/ 2024-10-22T11:57:05+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Royalty-Pharma-Announces-Second-Quarter-2024-Financial-Results_11zon.webp https://thepharmadata.com/vsee-health-expands-telehealth-services-with-new-glp-1-program-to-tackle-obesity-and-chronic-disease/ 2024-10-22T14:09:39+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Telehealth-Service.webp https://thepharmadata.com/waltz-health-and-noom-partner-to-bring-a-comprehensive-and-more-affordable-weight-loss-program-to-employers/ 2024-10-22T14:12:06+05:30 https://thepharmadata.com/wp-content/uploads/2023/06/weight-loss-_2_.webp https://thepharmadata.com/fda-approves-ngs-based-companion-diagnostic-for-first-targeted-therapy-in-patients-with-grade-2-idh-mutant-glioma/ 2024-10-22T14:16:24+05:30 https://thepharmadata.com/wp-content/uploads/2024/03/Bio-Techne-Attains-European-IVDR-Certification-for-Diagnostic-Test-Monitoring-Chronic-Myeloid-Leukemia.webp https://thepharmadata.com/hemohim-manufacturer-kolmar-bnh-receives-nai-classification-from-u-s-fda/ 2024-10-22T14:21:46+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/HemoHim.webp https://thepharmadata.com/nucleus-radiopharma-boosts-radiopharmaceutical-rd-and-production-to-address-u-s-supply-chain-challenges/ 2024-10-22T14:28:06+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Nucleus-RadioPharma.webp https://thepharmadata.com/viz-ai-expands-into-lung-disease-to-accelerate-diagnosis-and-care-for-patients/ 2024-10-22T14:34:08+05:30 https://thepharmadata.com/wp-content/uploads/2024/09/Computational-TROP2-Biomarker-Predicts-Outcomes-for-Datopotamab-Deruxtecan-in-TROPION-Lung01-Phase-III-Trial.webp https://thepharmadata.com/bioptimus-and-proscia-partner-to-advance-ai-in-research-and-drug-development/ 2024-10-24T09:59:55+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Bioptimus-and-Proscia-Partner-to-Advance-AI-in-Research-and-Drug-Development.webp https://thepharmadata.com/redwire-and-bristol-myers-squibb-launch-space-mission-to-study-drug-compounds/ 2024-10-24T10:07:07+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Redwire-and-Bristol-Myers-Squibb-Launch-Space-Mission-to-Study-Drug-Compounds.webp https://thepharmadata.com/opioid-use-in-california-workers-comp-drops-faster-than-in-general-population/ 2024-10-24T10:12:57+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Opioid-Use-in-California-Workers-Comp-Drops-Faster-Than-in-General-Population.webp https://thepharmadata.com/nimmune-biopharma-secures-asian-rights-to-develop-and-commercialize-omilancor/ 2024-10-24T10:17:42+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/NImmune-Biopharma-Secures-Asian-Rights-to-Develop-and-Commercialize-Omilancor.webp https://thepharmadata.com/medgenome-names-felix-olale-m-d-ph-d-as-ceo-and-jennifer-rose-as-cco-to-drive-u-s-expansion/ 2024-10-24T10:21:37+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/MedGenome-Names-Felix-Olale-M.D.-Ph.D.-as-CEO-and-Jennifer-Rose-as-CCO-to-Drive-U.S.-Expansion.webp https://thepharmadata.com/valor-compounding-pharmacy-seeks-new-partnerships-with-medical-practices-and-hospital-systems/ 2024-10-24T10:25:51+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Valor-Compounding-Pharmacy-Seeks-New-Partnerships-with-Medical-Practices-and-Hospital-Systems.webp https://thepharmadata.com/aulos-bioscience-unveils-phase-2-data-for-il-2-antibody-au-007-at-eortc-nci-aacr-symposium/ 2024-10-24T10:31:16+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Aulos-Bioscience-Unveils-Phase-2-Data-for-IL-2-Antibody-AU-007-at-EORTC-NCI-AACR-Symposium.webp https://thepharmadata.com/groundbreaking-ai-powered-solutions-for-consumer-controlled-health-information-management/ 2024-10-24T10:37:41+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Groundbreaking-AI-Powered-Solutions-for-Consumer-Controlled-Health-Information-Management.webp https://thepharmadata.com/integrated-inspection-and-pv2-automation-lower-pharmacy-costs/ 2024-10-25T09:55:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Integrated-Inspection-and-PV2-Automation-Lower-Pharmacy-Costs.webp https://thepharmadata.com/shields-health-and-sutter-health-expand-access-to-specialty-pharmacy-services/ 2024-10-25T09:59:13+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Shields-Health-and-Sutter-Health-Expand-Access-to-Specialty-Pharmacy-Services.webp https://thepharmadata.com/pharmajet-study-tropis-needle-free-system-boosts-polio-immunization-coverage-and-cuts-costs/ 2024-10-25T10:04:51+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/PharmaJet-Study-Tropis®-Needle-Free-System-Boosts-Polio-Immunization-Coverage-and-Cuts-Costs.webp https://thepharmadata.com/havah-therapeutics-forms-clinical-advisory-board-to-advance-new-breast-cancer-treatment/ 2024-10-25T10:09:13+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Havah-Therapeutics-Forms-Clinical-Advisory-Board-to-Advance-New-Breast-Cancer-Treatment.webp https://thepharmadata.com/guardian-study-reveals-benefits-of-genome-sequencing-in-newborn-screening/ 2024-10-25T10:13:34+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/GUARDIAN-Study-Reveals-Benefits-of-Genome-Sequencing-in-Newborn-Screening.webp https://thepharmadata.com/median-technologies-releases-q3-2024-operational-and-financial-update/ 2024-10-25T10:19:23+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Median-Technologies-Releases-Q3-2024-Operational-and-Financial-Update.webp https://thepharmadata.com/2024-2029-ai-based-drug-repurposing-market-growth-report-accelerating-drug-development/ 2024-10-25T10:24:36+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/2024-2029-AI-Based-Drug-Repurposing-Market-Growth-Report-Accelerating-Drug-Development.webp https://thepharmadata.com/merz-therapeutics-and-world-stroke-organization-launch-initiative-to-enhance-stroke-treatment-in-africa/ 2024-10-25T10:29:16+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Merz-Therapeutics-and-World-Stroke-Organization-Launch-Initiative-to-Enhance-Stroke-Treatment-in-Africa.webp https://thepharmadata.com/gensight-biologics-provides-business-update-and-cash-position-as-of-september-30-2024/ 2024-10-25T10:33:25+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/GenSight-Biologics-Provides-Business-Update-and-Cash-Position-as-of-September-30-2024.webp https://thepharmadata.com/d-a-davidson-guides-allivet-inc-in-its-upcoming-sale-to-tractor-supply-company/ 2024-10-25T10:39:20+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/D.A.-Davidson-Guides-Allivet-Inc.-in-Its-Upcoming-Sale-to-Tractor-Supply-Company.webp https://thepharmadata.com/revolution-medicines-reports-initial-data-on-rmc-9805-monotherapy-in-advanced-pancreatic-cancer/ 2024-10-26T10:24:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Medicines-Reports_11zon.webp https://thepharmadata.com/inaugural-meeting-of-the-acute-care-action-network/ 2024-10-26T10:31:42+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Inaugural-Meeting-of-the-Acute-Care-Action-Network_11zon.webp https://thepharmadata.com/walgreens-prescription-delivery-everything-you-need-to-know/ 2024-10-26T10:41:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Walgreens-Prescription-Delivery-Everything-You-Need-to-Know_11zon.webp https://thepharmadata.com/every-day-without-vision-is-one-too-many-tackling-the-impact-of-eye-diseases/ 2024-10-26T10:47:31+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Tackling-the-Impact-of-Eye-Diseases_11zon.webp https://thepharmadata.com/vertex-provides-kidney-program-updates-at-asn-kidney-week-congress/ 2024-10-26T11:06:43+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Vertex-Provides-Kidney-Program-Updates-at-ASN-Kidney-Week-Congress_11zon_11zon.webp https://thepharmadata.com/lillys-ebglyss-achieves-skin-clearance-and-itch-relief-in-atopic-dermatitis-patients/ 2024-10-26T11:32:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Lillys-EBGLYSS™-Achieves-Skin-Clearance-and-Itch-Relief-in-Atopic-Dermatitis-Patients-2.webp https://thepharmadata.com/evecxia-therapeutics-successfully-completes-pre-ind-meeting-with-fda-on-evx-101-development-for-depression/ 2024-10-26T11:40:23+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Evecxia-Therapeutics-Successfully-Completes_11zon.webp https://thepharmadata.com/biohub-maryland-launches-biopharma-workforce-training-center-in-montgomery-countys-life-sciences-corridor/ 2024-10-26T11:45:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/BioHub-Maryland-Launches-Biopharma-Workforce-Training-Center-in-Montgomery-Countys-Life-Sciences-Corridor_11zon.webp https://thepharmadata.com/maze-therapeutics-announces-positive-phase-1-data-for-mze829-in-treating-apol1-kidney-disease/ 2024-10-26T11:49:50+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Maze-Therapeutics-Announces-Positive-Phase-1-Data-for-MZE829-in-Treating-APOL1-Kidney-Disease_11zon.webp https://thepharmadata.com/labgenomics-usa-finalizes-acquisition-of-imd-clia-labs/ 2024-10-26T11:53:38+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/LabGenomics-USA-Finalizes-Acquisition-of-IMD-CLIA-Labs_11zon.webp https://thepharmadata.com/felix-health-launches-first-national-menopause-show-for-women-in-perimenopause-and-beyond/ 2024-10-26T12:06:42+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Komodo-Health-Unveils-Real-Time-Drug-Prescription-Insights.webp https://thepharmadata.com/engene-secures-60-million-in-private-placement-financing/ 2024-10-26T12:11:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/enGene-Secures-60-Million-in-Private-Placement-Financing_11zon.webp https://thepharmadata.com/dr-reddys-recognized-by-science-magazine-as-a-top-20-global-pharma-employer-for-the-third-year-in-a-row/ 2024-10-26T12:17:56+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Global-Pharma-Employer-for-the-Third-Year-in-a-Row_11zon.webp https://thepharmadata.com/biogen-shares-positive-phase-2-results-for-felzartamab-in-iga-nephropathy-at-asn-kidney-week-2024/ 2024-10-28T10:09:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Biogen-Shares-Positive-Phase-2-Results-for-Felzartamab-in-IgA-Nephropathy-at-ASN-Kidney-Week-2024_11zon.webp https://thepharmadata.com/astellas-updates-on-european-union-marketing-authorization-application-for-avacincaptad-pegol-acp/ 2024-10-28T10:17:04+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Astellas-Updates-on-European-Union-Marketing-Authorization-Application-for-Avacincaptad-Pegol-ACP_11zon-1.webp https://thepharmadata.com/novartis-oral-fabhalta-shows-sustained-benefits-in-one-year-phase-iii-c3g-trial/ 2024-10-28T10:28:05+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Novartis-Oral-Fabhalta®-Shows-Sustained-Benefits-in-One-Year-Phase-III-C3G-Trial.webp https://thepharmadata.com/judo-bio-reveals-data-on-gene-silencing-via-receptor-mediated-oligonucleotide-delivery-in-the-kidney/ 2024-10-28T10:44:55+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Judo-Bio-Reveals-Data-on-Gene-Silencing-2_11zon_11zon-scaled.webp https://thepharmadata.com/odyssey-therapeutics-to-present-data-on-od-07656-at-acg-annual-scientific-meeting-2024/ 2024-10-28T10:55:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Odyssey-Therapeutics-to-Present-Data_11zon.webp https://thepharmadata.com/lupin-prioritizes-development-of-inhalers-with-eco-friendly-low-global-warming-propellants/ 2024-10-29T09:57:15+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Lupin-Prioritizes-Development-of-Inhalers.webp https://thepharmadata.com/wuxi-biologics-introduces-wuxia-ridgs-platform-for-antibiotic-free-cell-line-development/ 2024-10-29T10:05:21+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Antibiotic-Free-Cell-Line-Development.webp https://thepharmadata.com/michael-mcdonnell-evp-cfo-to-retire-in-february-2025/ 2024-10-29T10:15:24+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Michael-McDonnell-EVP-CFO-to-Retire-in-February-2025.webp https://thepharmadata.com/merck-and-moderna-launch-phase-3-trial-of-v940-and-keytruda-combo-in-non-small-cell-lung-cancer/ 2024-10-29T10:25:16+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Merck-and-Moderna-Launch-Phase-3-Trial-of-V940-and-KEYTRUDA®-Combo-in-Non-Small-Cell-Lung-Cancer.webp https://thepharmadata.com/walgreens-expands-virtual-healthcare-to-30-states-adds-lab-tests-and-std-treatments/ 2024-10-29T10:30:52+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Lab-Tests-and-STD-Treatments.webp https://thepharmadata.com/astellas-updates-on-marketing-authorization-application-for-avacincaptad-pegol-acp-in-the-eu/ 2024-10-29T10:34:37+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Astellas-Updates-on-Marketing-Authorization-Application.webp https://thepharmadata.com/abbvie-acquires-aliada-therapeutics-to-strengthen-alzheimers-and-neuroscience-commitment/ 2024-10-29T10:42:40+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Alzheimers-and-Neuroscience-Commitment.webp https://thepharmadata.com/interpath-009-trial-expands-v940-clinical-program-targeting-earlier-cancer-stages/ 2024-10-29T10:48:50+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Targeting-Earlier-Cancer-Stages.webp https://thepharmadata.com/alliance-for-transformative-action-on-climate-and-health-restructured-at-general-meeting/ 2024-10-30T10:07:54+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Health-Restructured-at-General-Meeting_11zon.webp https://thepharmadata.com/tuberculosis-returns-as-leading-infectious-disease-killer/ 2024-10-30T10:18:29+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Tuberculosis-Returns-as-Leading-Infectious-Disease-Killer_11zon-1.webp https://thepharmadata.com/who-activates-global-health-emergency-corps-for-first-time-in-response-to-mpox-outbreak/ 2024-10-30T10:22:21+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/WHO-Activates-Global-Health-Emergency-Corps-for-First-Time-in-Response-to-Mpox-Outbreak_11zon.webp https://thepharmadata.com/exelixis-reports-q3-2024-financial-results-and-corporate-update/ 2024-10-30T10:26:35+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Exelixis-Reports-Q3-2024-Financial-Results-and-Corporate-Update_11zon.webp https://thepharmadata.com/viatris-recognized-on-forbes-2024-list-of-worlds-top-companies-for-women/ 2024-10-30T10:32:18+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Viatris-Recognized-on-Forbes-2024-List-of-Worlds-Top-Companies-for-Women.webp https://thepharmadata.com/scaleready-awards-g-rex-grant-to-luminary-therapeutics/ 2024-10-30T10:36:55+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/ScaleReady-Awards-G-Rex®-Grant-to-Luminary-Therapeutics.webp https://thepharmadata.com/skinspirit-and-allergan-aesthetics-team-up-to-empower-girls-inc-and-women-in-stem/ 2024-10-30T10:56:39+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/SkinSpirit-and-Allergan-Aesthetics-Team-Up-to-Empower-Girls-Inc.-and-Women-in-STEM_11zon.webp https://thepharmadata.com/18-year-old-pyry-shadows-svp-of-rd-for-a-day-i-aspire-to-make-a-social-impact/ 2024-11-01T09:55:10+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/18-Year-Old-Pyry-Shadows-SVP-of-RD-for-a-Day-I-Aspire-to-Make-a-Social-Impact.webp https://thepharmadata.com/bachems-sustainable-approach-to-tides-manufacturing/ 2024-11-01T10:02:27+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Bachems-Sustainable-Approach-to-TIDES-Manufacturing_11zon.webp https://thepharmadata.com/blueprint-medicines-q3-2024-results-increased-full-year-revenue-guidance-for-ayvakit-ayvakyt/ 2024-11-01T10:06:36+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Blueprint-Medicines-Q3-2024-Results-Increased-Full-Year-Revenue-Guidance_11zon.webp https://thepharmadata.com/halozyme-announces-q3-2024-financial-and-operational-results/ 2024-11-01T10:11:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Halozyme-Announces-Q3-2024-Financial-and-Operational-Results_11zon.webp https://thepharmadata.com/updated-consolidated-financial-forecasts-and-introduction-of-core-based-financial-reporting/ 2024-11-01T10:22:56+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Updated-Consolidated-Financial-Forecasts-and-Introduction-of-Core-Based-Financial-Reporting_11zon.webp https://thepharmadata.com/uganda-and-who-launch-strategies-to-enhance-healthcare-for-refugees-and-migrants/ 2024-11-01T10:36:18+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Uganda-and-WHO-Launch-Strategies-to-Enhance-Healthcare-for-Refugees-and-Migrants_11zon.webp https://thepharmadata.com/new-who-report-highlights-urban-efforts-in-preventing-ncds-and-injuries/ 2024-11-01T11:01:37+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/New-WHO-Report-Highlights-Urban-Efforts-in-Preventing-NCDs-and-Injuries_11zon.webp https://thepharmadata.com/teva-presents-new-td-data-at-psych-congress-2024-highlighting-patient-differences/ 2024-11-02T10:11:34+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Teva-Presents-New-TD-Data-at-Psych-Congress-2024-Highlighting-Patient-Differences_11zon.webp https://thepharmadata.com/teva-unveils-new-schizophrenia-research-positive-phase-3-tev-749-and-uzedy-data/ 2024-11-02T10:22:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Teva-Unveils-New-Schizophrenia-Research_11zon.webp https://thepharmadata.com/asn-2024-hansoh-pharma-shares-post-hoc-results-from-phase-iii-pegmolesatide-study/ 2024-11-02T10:28:53+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Hansoh-Pharma-Shares-Post-Hoc-Results-from-Phase-III-Pegmolesatide-Study_11zon.webp https://thepharmadata.com/ma-xin-jiangsu-vice-governor-visits-hansoh-pharma-subsidiary/ 2024-11-02T10:33:40+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Ma-Xin-Jiangsu-Vice-Governor-Visits-Hansoh-Pharma-Subsidiary_11zon.webp https://thepharmadata.com/lilly-to-present-phase-3-ember-3-study-results-for-imlunestrant-at-san-antonio-breast-cancer-symposium/ 2024-11-02T10:53:30+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Lilly-to-Present-Phase-3-EMBER-3-Study-Results-for-Imlunestrant-at-San-Antonio-Breast-Cancer-Symposium_11zon.webp https://thepharmadata.com/vir-biotechnology-releases-q3-2024-financial-results-and-corporate-update/ 2024-11-02T10:58:57+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Vir-Biotechnology-Releases-Q3-2024-Financial-Results-and-Corporate-Update_11zon.webp https://thepharmadata.com/medidata-and-cogstate-partner-to-enhance-neurology-clinical-trials-with-ai-solutions/ 2024-11-02T11:05:55+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Medidata-and-Cogstate-Partner-to-Enhance-Neurology-Clinical-Trials-with-AI-Solutions_11zon.webp https://thepharmadata.com/kashiv-biosciences-names-dr-sandeep-nilkanth-athalye-as-global-ceo/ 2024-11-02T11:09:38+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Kashiv-BioSciences-Names-Dr.-Sandeep-Nilkanth-Athalye-as-Global-CEO_11zon.webp https://thepharmadata.com/libra-therapeutics-names-dr-shawn-a-scranton-as-president-and-ceo/ 2024-11-02T11:14:22+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Libra-Therapeutics-Names-Dr.-Shawn-A.-Scranton-as-President-and-CEO_11zon.webp https://thepharmadata.com/arrowhead-pharmaceuticals-launches-well-get-there-soon-campaign-for-familial-chylomicronemia-syndrome-awareness/ 2024-11-05T10:27:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Blueprint-Medicines-Q3-2024-Results-Increased-Full-Year-Revenue-Guidance_11zon.webp https://thepharmadata.com/who-study-identifies-key-endemic-pathogens-in-urgent-need-of-new-vaccines/ 2024-11-05T10:09:20+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/WHO-Study-Identifies-Key-Endemic-Pathogens-in-Urgent-Need-of-New-Vaccines_11zon.webp https://thepharmadata.com/ionis-announces-fda-review-of-donidalorsen-nda-for-preventive-treatment-of-hae/ 2024-11-05T10:17:41+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Ionis-Announces-FDA-Review-of-Donidalorsen-NDA-for-Preventive-Treatment-of-HAE_11zon.webp https://thepharmadata.com/neurocrine-biosciences-shows-long-term-benefits-of-ingrezza-for-tardive-dyskinesia/ 2024-11-05T10:33:34+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Neurocrine-Biosciences-Shows-Long-Term-Benefits-of-INGREZZA®-for-Tardive-Dyskinesia.webp https://thepharmadata.com/neurocrine-biosciences-reveals-ingrezza-data-most-achieve-tardive-dyskinesia-remission/ 2024-11-05T10:56:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Neurocrine-Biosciences-Reveals-INGREZZA®-Data-Most-Achieve-Tardive-Dyskinesia-Remission.webp https://thepharmadata.com/legend-biotech-names-alan-bash-as-president-of-carvykti/ 2024-11-05T10:45:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Legend-Biotech-Names-Alan-Bash-as-President-of-CARVYKTI_11zon.webp https://thepharmadata.com/biontech-reports-financial-results-and-corporate-developments-for-q3-2024/ 2024-11-05T13:00:30+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/BioNTech-Reports-Financial-Results-and-Corporate-Developments-for-Q3-2024_11zon.webp https://thepharmadata.com/royalty-pharma-and-syndax-pharmaceuticals-strike-350m-royalty-deal-for-niktimvo/ 2024-11-05T11:02:13+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Royalty-Pharma-and-Syndax-Pharmaceuticals-Strike-350M-Royalty-Deal-for-Niktimvo_11zon.webp https://thepharmadata.com/bridgebio-case-study-on-portfolio-theory-in-biomedical-innovation-published-in-jpm/ 2024-11-07T10:03:50+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/BridgeBio-Case-Study-on-Portfolio-Theory-in-Biomedical-Innovation-Published-in-JPM_11zon.webp https://thepharmadata.com/intra-cellular-therapies-reports-positive-phase-3-results-for-caplyta-in-preventing-schizophrenia-relapse/ 2024-11-07T10:21:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Intra-Cellular-Therapies-Reports-Positive-Phase-3-Results-for-CAPLYTA-in-Preventing-Schizophrenia-Relapse_11zon.webp https://thepharmadata.com/crispr-therapeutics-shares-business-update-and-announces-q3-2024-financial-results/ 2024-11-07T10:35:50+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/CRISPR-Therapeutics-Shares-Business-Update-and-Announces-Q3-2024-Financial-Results_11zon.webp https://thepharmadata.com/revolution-medicines-announces-q3-2024-financial-results-and-provides-corporate-update/ 2024-11-07T10:39:29+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Revolution-Medicines-Announces-Q3-2024-Financial-Results-and-Provides-Corporate-Update_11zon.webp https://thepharmadata.com/ionis-unveils-phase-3-trial-design-for-ion582-in-angelman-syndrome/ 2024-11-07T10:54:29+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Ionis-Unveils-Phase-3-Trial-Design-for-ION582-in-Angelman-Syndrome_11zon.webp https://thepharmadata.com/teva-reports-strong-q3-2024-results-boosted-by-generics-and-innovation-raises-2024-financial-outlook/ 2024-11-07T11:05:40+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Teva-Reports-Strong-Q3-2024-Results-Boosted-by-Generics-and-Innovation-Raises-2024-Financial-Outlook_11zon.webp https://thepharmadata.com/legend-biotech-to-present-landmark-cartitude-4-trial-data-on-minimal-residual-disease-in-multiple-myeloma/ 2024-11-07T11:12:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Legend-Biotech-to-Present-Landmark-CARTITUDE-4-Trial-Data-on-Minimal-Residual-Disease-in-Multiple-Myeloma_11zon.webp https://thepharmadata.com/sarepta-therapeutics-reports-third-quarter-2024-financial-results-and-key-corporate-updates/ 2024-11-07T11:16:58+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Sarepta-Therapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Key-Corporate-Updates_11zon.webp https://thepharmadata.com/joint-statement-from-the-who-director-general-and-the-who-civil-society-task-force-on-tuberculosis/ 2024-11-07T11:24:15+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Joint-Statement-from-the-WHO-Director-General-and-the-WHO-Civil-Society-Task-Force-on-Tuberculosis_11zon.webp https://thepharmadata.com/vaccine-doses-assigned-to-9-african-countries-affected-by-mpox-surge/ 2024-11-07T11:27:48+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Vaccine-Doses-Assigned-to-9-African-Countries-Affected-by-Mpox-Surge_11zon.webp https://thepharmadata.com/unicef-and-who-announce-completion-of-second-round-of-polio-campaign-in-gaza-amid-ongoing-conflict/ 2024-11-07T11:41:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/UNICEF-and-WHO-Announce-Completion-of-Second-Round-of-Polio-Campaign-in-Gaza-Amid-Ongoing-Conflict.webp https://thepharmadata.com/wuxi-biologics-achieves-aaa-msci-esg-rating-for-the-second-consecutive-year/ 2024-11-07T11:53:16+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/WuXi-Biologics-Achieves-AAA-MSCI-ESG-Rating-for-the-Second-Consecutive-Year_11zon-1.webp https://thepharmadata.com/astrazeneca-highlights-strength-of-hematology-portfolio-and-pipeline-at-ash-2024/ 2024-11-08T10:02:25+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/AstraZeneca-Highlights-Strength-of-Hematology-Portfolio-and-Pipeline-at-ASH-2024_11zon.webp https://thepharmadata.com/allergan-aesthetics-marks-annual-botox-cosmetic-onabotulinumtoxina-day-celebration/ 2024-11-08T10:13:43+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Allergan-Aesthetics-Marks-Annual-BOTOX®-Cosmetic-onabotulinumtoxinA-Day-Celebration.webp https://thepharmadata.com/gilead-presents-late-breaking-data-at-hiv-glasgow-advancing-efforts-to-end-the-epidemic/ 2024-11-08T10:21:11+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Gilead-Presents-Late-Breaking-Data-at-HIV-Glasgow-Advancing-Efforts-to-End-the-Epidemic_11zon.webp https://thepharmadata.com/askbios-ab-1003-granted-fda-rare-pediatric-disease-and-orphan-drug-designations/ 2024-11-08T10:30:33+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/AskBios-AB-1003-Granted-FDA-Rare-Pediatric-Disease-and-Orphan-Drug-Designations_11zon.webp https://thepharmadata.com/royalty-pharma-acquires-125-million-royalty-stake-in-gerons-rytelo/ 2024-11-09T10:29:42+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Royalty-Pharma-Acquires-125-Million-Royalty-Stake-in-Gerons-Rytelo_11zon.webp https://thepharmadata.com/essential-facts-about-otc-phenylephrine-for-cold-and-flu-season/ 2024-11-09T10:36:20+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Essential-Facts-About-OTC-Phenylephrine-for-Cold-and-Flu-Season_11zon.webp https://thepharmadata.com/health-canada-approves-modernas-rsv-vaccine-for-adults-60-and-older/ 2024-11-09T10:42:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Health-Canada-Approves-Modernas-RSV-Vaccine-for-Adults-60-and-Older_11zon.webp https://thepharmadata.com/tezspire-achieves-both-primary-goals-in-phase-iii-waypoint-trial-for-chronic-rhinosinusitis-with-nasal-polyps/ 2024-11-09T10:58:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Tezspire-Achieves-Both-Primary-Goals-in-Phase-III-WAYPOINT-Trial-for-Chronic-Rhinosinusitis-with-Nasal-Polyps_11zon.webp https://thepharmadata.com/beigene-showcases-innovative-hematology-portfolio-for-b-cell-malignancies-at-ash-2024/ 2024-11-09T11:12:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/BeiGene-Showcases-Innovative-Hematology-Portfolio-for-B-cell-Malignancies-at-ASH-2024_11zon.webp https://thepharmadata.com/tempus-to-present-nine-abstracts-at-the-2024-society-for-immunotherapy-of-cancer-annual-meeting/ 2024-11-09T11:16:08+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Tempus-to-Present-Nine-Abstracts-at-the-2024-Society-for-Immunotherapy-of-Cancer-Annual-Meeting_11zon.webp https://thepharmadata.com/free-heart-and-kidney-health-screenings-offered-in-houston-from-nov-11-14/ 2024-11-09T11:23:28+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Free-Heart-and-Kidney-Health-Screenings-Offered-in-Houston-from-Nov.-11-14_11zon.webp https://thepharmadata.com/baxter-announces-third-quarter-2024-financial-results/ 2024-11-09T11:27:03+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Baxter-Announces-Third-Quarter-2024-Financial-Results_11zon.webp https://thepharmadata.com/brenus-pharma-publishes-positive-proof-of-concept-results-in-scientific-frontiers-in-oncology/ 2024-11-13T12:19:58+05:30 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/kanvas-bio-presents-clinical-data-on-gut-microbiomes-role-in-anti-tumoral-immunity-at-sitc/ 2024-11-09T13:28:11+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Kanvas-Bio-Presents-Clinical-Data-on-Gut-Microbiomes-Role-in-Anti-Tumoral-Immunity-at-SITC_11zon_11zon.webp https://thepharmadata.com/vivolta-teams-up-with-neurochase-to-produce-electrospun-micro-catheters-for-advanced-cns-brain-therapies/ 2024-11-14T12:12:57+05:30 https://thepharmadata.com/wp-content/uploads/2024/10/Regional-Study-Shows-Blood-Biomarkers-Can-Predict-Brain-Amyloid-Beta-Accumulation.webp https://thepharmadata.com/gilead-presents-full-purpose-2-data-results-for-twice-yearly-lenacapavir-for-hiv-prevention-at-hiv-glasgow/ 2024-11-14T12:16:37+05:30 https://thepharmadata.com/wp-content/uploads/2023/07/HIV.webp https://thepharmadata.com/reverb-therapeutics-to-collaborate-with-royalmount-laboratories-on-development-of-advanced-bispecific-antibodies/ 2024-11-14T12:18:27+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Hinge-Health-and-Midi-Health-Collaborate-to-Offer-Comprehensive-Menopause-Care.webp https://thepharmadata.com/enveda-announces-first-candidate-discovered-from-nature-using-ai-advances-to-clinical-trials/ 2024-11-14T14:11:12+05:30 https://thepharmadata.com/wp-content/uploads/2023/09/announces-_4_.webp https://thepharmadata.com/leaders-gather-at-the-milken-institute-2024-future-of-health-summit-to-address-global-health-issues/ 2024-11-14T14:35:59+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Milken-Institute.webp https://thepharmadata.com/trexbio-secures-84-million-in-series-b-funding-to-advance-its-first-in-class-immunology-programs-into-clinical-trials/ 2024-11-14T14:19:51+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/immunology.webp https://thepharmadata.com/qps-launches-new-leukopak-and-cell-therapy-products-facility/ 2024-11-14T14:25:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Therapy-Products-Facility.webp https://thepharmadata.com/astrazeneca-invests-3-5-billion-in-u-s-rd-and-production/ 2024-11-14T14:34:03+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/AstraZeneca-2.webp https://thepharmadata.com/lumicells-board-of-directors-appoints-howard-hechler-as-chief-executive-officer/ 2024-11-14T14:39:39+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Howard-Hechler.webp https://thepharmadata.com/americans-continue-to-struggle-to-access-branded-glp-1s-as-shortages-continue/ 2024-11-14T14:43:18+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Americans-Continue-to-Struggle-to-Access-Branded-GLP-1s-as-Shortages-Continue.webp https://thepharmadata.com/equillium-reports-q3-2024-financial-results-and-shares-corporate-and-clinical-updates/ 2024-11-14T14:46:12+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Equillium-reports-Q3-2024-financial-results-and-shares-corporate-and-clinical-updates.webp https://thepharmadata.com/greywolf-appoints-darlene-deptula-hicks-as-chief-financial-officer/ 2024-11-14T14:56:55+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Darlene-Deptula-Hicks-_2_.webp https://thepharmadata.com/merck-receives-positive-eu-chmp-opinion-for-keytruda/ 2024-11-16T10:23:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Merck.webp https://thepharmadata.com/who-and-partners-unite-in-efforts-to-eliminate-cervical-cancer/ 2024-11-18T09:21:57+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/WHO-and-Partners-Unite-in-Efforts-to-Eliminate-Cervical-Cancer_11zon.webp https://thepharmadata.com/alnylam-reports-phase-1-data-nucresiran-shows-rapid-sustained-ttr-knockdown-after-one-dose/ 2024-11-18T09:53:07+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Alnylam-Reports-Phase-1-Data-Nucresiran-Shows-Rapid-Sustained-TTR-Knockdown-After-One-Dose_11zon.webp https://thepharmadata.com/extended-data-confirms-acoramidis-sustains-cardiovascular-benefits-reduces-acm-at-36-months/ 2024-11-19T09:21:13+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Extended-Data-Confirms-Acoramidis-Sustains-Cardiovascular-Benefits-Reduces-ACM-at-36-Months_11zon.webp https://thepharmadata.com/bridgebio-publishes-phase-2-infigratinib-study-for-achondroplasia-in-nejm/ 2024-11-19T09:27:56+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/BridgeBio-Publishes-Phase-2-Infigratinib-Study-for-Achondroplasia-in-NEJM_11zon.webp https://thepharmadata.com/halozyme-shares-update-on-potential-merger-proposal-with-evotec/ 2024-11-19T09:35:14+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Halozyme-Shares-Update-on-Potential-Merger-Proposal-with-Evotec_11zon.webp https://thepharmadata.com/baku-cop29-strengthens-health-climate-initiatives-with-launch-of-new-coalition/ 2024-11-19T09:44:14+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Baku-COP29-Strengthens-Health-Climate-Initiatives-with-Launch-of-New-Coalition_11zon.webp https://thepharmadata.com/hospital-data-reveals-new-insights-on-maternal-and-newborn-health-in-nigeria/ 2024-11-19T09:49:50+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Hospital-Data-Reveals-New-Insights-on-Maternal-and-Newborn-Health-in-Nigeria.webp https://thepharmadata.com/bylvay-data-shows-continued-improvement-in-itch-and-bile-acid-levels-in-pfic-and-algs/ 2024-11-19T10:20:10+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Bylvay®-Data-Shows-Continued-Improvement-in-Itch-and-Bile-Acid-Levels-in-PFIC-and-ALGS-2.webp https://thepharmadata.com/inebilizumab-earns-fda-breakthrough-designation-for-igg4-rd-new-data-at-acr-2024/ 2024-11-19T10:37:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Inebilizumab-Earns-FDA-Breakthrough-Designation-for-IgG4-RD-New-Data-at-ACR-2024.webp https://thepharmadata.com/astellas-updates-on-izervay-avacincaptad-pegol-supplemental-nda/ 2024-11-19T10:42:03+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Astellas-Updates-on-IZERVAY™-Avacincaptad-Pegol-Supplemental-NDA.webp https://thepharmadata.com/celltrion-shares-phase-iii-data-on-denosumab-and-tocilizumab-biosimilars-at-acr-2024/ 2024-11-19T10:48:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Celltrion-Shares-Phase-III-Data-on-Denosumab-and-Tocilizumab-Biosimilars-at-ACR-2024_11zon.webp https://thepharmadata.com/lillys-muvalaplin-reduces-lipoproteina-by-up-to-85-in-high-risk-adults/ 2024-11-19T10:53:40+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Lillys-Muvalaplin-Reduces-Lipoproteina-by-Up-to-85-in-High-Risk-Adults.webp https://thepharmadata.com/cvs-health-announces-new-board-appointments/ 2024-11-19T10:58:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/CVS-Health-Announces-New-Board-Appointments_11zon.webp https://thepharmadata.com/who-investment-round-a-defining-moment-at-g20-summit-with-leaders-pledges/ 2024-11-20T09:45:49+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/WHO-Investment-Round-A-Defining-Moment-at-G20-Summit-with-Leaders-Pledges_11zon.webp https://thepharmadata.com/dapirolizumab-pegol-phase-3-data-highlights-sle-disease-activity-reduction/ 2024-11-20T09:59:46+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Dapirolizumab-Pegol-Phase-3-Data-Highlights-SLE-Disease-Activity-Reduction_11zon.webp https://thepharmadata.com/astellas-shares-update-on-izervay-supplemental-new-drug-application/ 2024-11-20T10:05:36+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Astellas-Shares-Update-on-IZERVAY™-Supplemental-New-Drug-Application.webp https://thepharmadata.com/beigene-announces-settlement-with-generic-filer-of-brukinsa/ 2024-11-20T10:12:56+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/BeiGene-Announces-Settlement-with-Generic-Filer-of-BRUKINSA_11zon.webp https://thepharmadata.com/bayer-expands-cardiovascular-portfolio-with-cytokinetics-aficamten-in-japan/ 2024-11-20T10:22:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Bayer-Expands-Cardiovascular-Portfolio-with-Cytokinetics-Aficamten-in-Japan.webp https://thepharmadata.com/merck-announces-phase-3-trial-of-subcutaneous-pembrolizumab-with-berahyaluronidase-alfa/ 2024-11-20T10:34:36+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Merck-Announces-Phase-3-Trial-of-Subcutaneous-Pembrolizumab-with-Berahyaluronidase-Alfa.webp https://thepharmadata.com/novartis-tops-2024-access-to-medicine-index/ 2024-11-20T10:39:48+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Novartis-Tops-2024-Access-to-Medicine-Index_11zon.webp https://thepharmadata.com/cvs-health-becomes-first-healthcare-company-to-earn-urac-health-equity-accreditation/ 2024-11-20T10:51:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/CVS-Health®-Becomes-First-Healthcare-Company-to-Earn-URAC-Health-Equity-Accreditation.webp https://thepharmadata.com/jazz-pharma-gains-fda-approval-for-ziihera-to-treat-advanced-her2-biliary-tract-cancer/ 2024-11-21T09:30:36+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Jazz-Pharma-Gains-FDA-Approval-for-Ziihera®-to-Treat-Advanced-HER2-Biliary-Tract-Cancer.webp https://thepharmadata.com/local-climate-action-global-health-benefits/ 2024-11-21T09:38:14+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Local-Climate-Action-Global-Health-Benefits_11zon_11zon.webp https://thepharmadata.com/improving-access-to-pediatric-medicines-on-world-childrens-day/ 2024-11-21T09:47:30+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Improving-Access-to-Pediatric-Medicines-on-World-Childrens-Day.webp https://thepharmadata.com/bio-techne-signs-distribution-agreement-with-leader-life-sciences/ 2024-11-21T09:54:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Bio-Techne-Signs-Distribution-Agreement-with-Leader-Life-Sciences_11zon.webp https://thepharmadata.com/tasfygo-tablets-35mg-launched-in-japan-for-fgfr2-positive-biliary-tract-cancer/ 2024-11-21T09:57:22+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Tasfygo®-Tablets-35mg-Launched-in-Japan-for-FGFR2-Positive-Biliary-Tract-Cancer.webp https://thepharmadata.com/eu-approves-pfizers-hympavzi-for-severe-hemophilia-a-b-in-adults-and-adolescents/ 2024-11-21T10:09:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/EU-Approves-Pfizers-HYMPAVZI™-for-Severe-Hemophilia-AB-in-Adults-and-Adolescents.webp https://thepharmadata.com/pfizer-appoints-new-chief-scientific-officer-and-president-of-rd/ 2024-11-21T10:25:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Pfizer-Appoints-New-Chief-Scientific-Officer-and-President-of-RD.webp https://thepharmadata.com/omeros-corporation-shares-update-on-bla-resubmission-progress/ 2024-11-22T09:59:48+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Omeros-Corporation-Shares-Update-on-BLA-Resubmission-Progress_11zon.webp https://thepharmadata.com/trinity-life-sciences-advocates-transformative-approach-to-evaluating-field-medical-affairs-impact/ 2024-11-22T10:06:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Trinity-Life-Sciences-Advocates-Transformative-Approach-to-Evaluating-Field-Medical-Affairs-Impact_11zon_11zon.webp https://thepharmadata.com/institut-curie-adopts-ibex-medical-analytics-ai-tools-to-advance-cancer-diagnostics/ 2024-11-22T10:11:14+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Institut-Curie-Adopts-Ibex-Medical-Analytics-AI-Tools-to-Advance-Cancer-Diagnostics.webp https://thepharmadata.com/northstar-and-cellectar-partner-on-actinium-225-supply-agreement/ 2024-11-22T10:17:23+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/NorthStar-and-Cellectar-Partner-on-Actinium-225-Supply-Agreement_11zon.webp https://thepharmadata.com/altasciences-partners-with-metsera-for-early-stage-obesity-clinical-trials/ 2024-11-22T10:20:48+05:30 https://thepharmadata.com/wp-content/uploads/2024/11/Altasciences-Partners-with-Metsera-for-Early-Stage-Obesity-Clinical-Trials_11zon.webp